SCHEMBL6433863

SCHEMBL6433863

OC(CNC1(Cc2cccc(OC(F)(F)C(F)F)c2)CCCC(OC2CCCC2)C1)C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CETP P11597 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669779 0.93 CETP (0.42) CETP
SCHEMBL5670064 0.90 CETP (0.51) CETP
SCHEMBL5668807 0.90 CETP (0.46) CETP
SCHEMBL5672263 0.88 CETP (0.47) CETP
SCHEMBL5669750 0.84 CETP (0.32) CETP
SCHEMBL6276333 0.83 CETP (0.48) CETP
SCHEMBL6567860 0.83 CETP (0.50) CETP
SCHEMBL5669311 0.82 CETP (0.41) CETP
SCHEMBL6568532 0.82 CETP (0.45) CETP
SCHEMBL6571577 0.80 CETP (0.44) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581210-A1 DOSAGE FORMS COMPRISING A CETP INHIBITOR AND AN HMG-COA REDUCTASE INHIBITOR Pfizer Products Inc. (US) 2005-10-05 EP disclosed
WO-2004056359-A1 DOSAGE FORMS COMPRISING A CETP INHIBITOR AND AN HMG-COA REDUCTASE INHIBITOR PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed